These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31314754)

  • 1. CC chemokine CCL1 receptor CCR8 mediates conversion of mesenchymal stem cells to embryoid bodies expressing FOXP3+CCR8+ regulatory T cells.
    Haque NS; Tuteja A; Haque N
    PLoS One; 2019; 14(7):e0218944. PubMed ID: 31314754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR8 expression identifies CD4 memory T cells enriched for FOXP3+ regulatory and Th2 effector lymphocytes.
    Soler D; Chapman TR; Poisson LR; Wang L; Cote-Sierra J; Ryan M; McDonald A; Badola S; Fedyk E; Coyle AJ; Hodge MR; Kolbeck R
    J Immunol; 2006 Nov; 177(10):6940-51. PubMed ID: 17082609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR8
    Barsheshet Y; Wildbaum G; Levy E; Vitenshtein A; Akinseye C; Griggs J; Lira SA; Karin N
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6086-6091. PubMed ID: 28533380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis.
    Zen Y; Liberal R; Nakanuma Y; Heaton N; Portmann B
    J Hepatol; 2013 Nov; 59(5):1059-64. PubMed ID: 23811304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion.
    Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC
    Blood; 2004 Feb; 103(4):1296-304. PubMed ID: 14576057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.
    Freeman CM; Chiu BC; Stolberg VR; Hu J; Zeibecoglou K; Lukacs NW; Lira SA; Kunkel SL; Chensue SW
    J Immunol; 2005 Feb; 174(4):1962-70. PubMed ID: 15699124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice.
    Vila-Caballer M; González-Granado JM; Zorita V; Abu Nabah YN; Silvestre-Roig C; Del Monte-Monge A; Molina-Sánchez P; Ait-Oufella H; Andrés-Manzano MJ; Sanz MJ; Weber C; Kremer L; Gutiérrez J; Mallat Z; Andrés V
    J Mol Cell Cardiol; 2019 Jul; 132():154-163. PubMed ID: 31121182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coordinated involvement of mast cells and T cells in allergic mucosal inflammation: critical role of the CC chemokine ligand 1:CCR8 axis.
    Gonzalo JA; Qiu Y; Lora JM; Al-Garawi A; Villeval JL; Boyce JA; Martinez-A C; Marquez G; Goya I; Hamid Q; Fraser CC; Picarella D; Cote-Sierra J; Hodge MR; Gutierrez-Ramos JC; Kolbeck R; Coyle AJ
    J Immunol; 2007 Aug; 179(3):1740-50. PubMed ID: 17641040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1
    Wang M; Qin Z; Wan J; Yan Y; Duan X; Yao X; Jiang Z; Li W; Qin Z
    Cancer Immunol Immunother; 2022 Nov; 71(11):2717-2730. PubMed ID: 35428909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule antagonists of CCR8 inhibit eosinophil and T cell migration.
    Karlsson AK; Walles K; Bladh H; Connolly S; Skrinjar M; Rosendahl A
    Biochem Biophys Res Commun; 2011 Apr; 407(4):764-71. PubMed ID: 21439940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL1 is a major regulatory T cell attracting factor in human breast cancer.
    Kuehnemuth B; Piseddu I; Wiedemann GM; Lauseker M; Kuhn C; Hofmann S; Schmoeckel E; Endres S; Mayr D; Jeschke U; Anz D
    BMC Cancer; 2018 Dec; 18(1):1278. PubMed ID: 30572845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR8-dependent activation of the RAS/MAPK pathway mediates anti-apoptotic activity of I-309/ CCL1 and vMIP-I.
    Louahed J; Struyf S; Demoulin JB; Parmentier M; Van Snick J; Van Damme J; Renauld JC
    Eur J Immunol; 2003 Feb; 33(2):494-501. PubMed ID: 12645948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.
    Iellem A; Mariani M; Lang R; Recalde H; Panina-Bordignon P; Sinigaglia F; D'Ambrosio D
    J Exp Med; 2001 Sep; 194(6):847-53. PubMed ID: 11560999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway.
    Spinetti G; Bernardini G; Camarda G; Mangoni A; Santoni A; Capogrossi MC; Napolitano M
    J Leukoc Biol; 2003 Jan; 73(1):201-7. PubMed ID: 12525579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist.
    Fox JM; Najarro P; Smith GL; Struyf S; Proost P; Pease JE
    J Biol Chem; 2006 Dec; 281(48):36652-61. PubMed ID: 17023422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orally bioavailable allosteric CCR8 antagonists inhibit dendritic cell, T cell and eosinophil migration.
    Connolly S; Skrinjar M; Rosendahl A
    Biochem Pharmacol; 2012 Mar; 83(6):778-87. PubMed ID: 22209712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation.
    Gombert M; Dieu-Nosjean MC; Winterberg F; Bünemann E; Kubitza RC; Da Cunha L; Haahtela A; Lehtimäki S; Müller A; Rieker J; Meller S; Pivarcsi A; Koreck A; Fridman WH; Zentgraf HW; Pavenstädt H; Amara A; Caux C; Kemeny L; Alenius H; Lauerma A; Ruzicka T; Zlotnik A; Homey B
    J Immunol; 2005 Apr; 174(8):5082-91. PubMed ID: 15814739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model.
    Zychowska M; Rojewska E; Piotrowska A; Kreiner G; Nalepa I; Mika J
    Int Immunopharmacol; 2017 Nov; 52():261-271. PubMed ID: 28961489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.
    Kidani Y; Nogami W; Yasumizu Y; Kawashima A; Tanaka A; Sonoda Y; Tona Y; Nashiki K; Matsumoto R; Hagiwara M; Osaki M; Dohi K; Kanazawa T; Ueyama A; Yoshikawa M; Yoshida T; Matsumoto M; Hojo K; Shinonome S; Yoshida H; Hirata M; Haruna M; Nakamura Y; Motooka D; Okuzaki D; Sugiyama Y; Kinoshita M; Okuno T; Kato T; Hatano K; Uemura M; Imamura R; Yokoi K; Tanemura A; Shintani Y; Kimura T; Nonomura N; Wada H; Mori M; Doki Y; Ohkura N; Sakaguchi S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(7):. PubMed ID: 35140181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
    Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
    J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.